Profiles of patients on warfarin anticoagulation therapy in a leading tertiary referral hospital in Kenya; findings and implications for Kenya

References

• Johnson MJ, Sproule MW, Paul J. The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer. Clin Oncol (R Coll Radiol). 1999;11(2):105–110.
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz A, Elfawwal MA. Incidence of deep venous thrombosis in stroke patients in medical intensive care unit Zagazig University Hospitals, Egypt. Zagazig Univ Med J. 2015;20(1):88–96.
   Google Scholar
• Ageno W, Gallus AS, Wittkowsky A, et al. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e44S–e88S.
   PubMed Web of Science ®Google Scholar
• Lowery S, Haley K, Bussey HI. Oral anticoagulation: challenges in the case-management setting. Lippincott’s Case Manage. 2005;10(1):39–50.
   PubMedGoogle Scholar
• Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Internal Med. 2005;165(10):1095–1106.
   PubMed Web of Science ®Google Scholar
• Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719–2747.
   PubMed Web of Science ®Google Scholar
• Yu HC, Chan TY, Critchley JA, et al. Factors determining the maintenance dose of warfarin in Chinese patients. QJM. 1996;89(2):127–135.
   PubMedGoogle Scholar
• Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2005;(3):Cd001927.
   PubMed Web of Science ®Google Scholar
• Manji I, Pastakia SD, Do AN, et al. Performance outcomes of a pharmacist-managed anticoagulation clinic in the rural, resource-constrained setting of Eldoret, Kenya. J Thromb Haemost. 2011;9(11):2215–2220.
   PubMed Web of Science ®Google Scholar
• Generalova D, Cunningham S, Leslie SJ, et al. A systematic review of clinicians’ views and experiences of direct-acting oral anticoagulants in the management of nonvalvular atrial fibrillation. Br J Clin Pharmacol. 2018;84(12):2692–2703.
   PubMed Web of Science ®Google Scholar
• Kim IS, Kim HJ, Kim TH, et al. Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis. J Cardiol. 2018;72(2):105–112.
   PubMed Web of Science ®Google Scholar
• Kamali F. Genetic influences on the response to warfarin. Curr Opin Hematol. 2006;13(5):357–361.
   PubMed Web of Science ®Google Scholar
• Tang Q, Zou H, Guo C, et al. Outcomes of pharmacogenetics-guided dosing of warfarin: a systematic review and meta-analysis. Int J Cardiol. 2014;175(3):587–591.
   PubMed Web of Science ®Google Scholar
• Loebstein R, Yonath H, Peleg D, et al. Interindividual variability in sensitivity to warfarin–nature or nurture? Clin Pharmacol Ther. 2001;70(2):159–164.
   PubMed Web of Science ®Google Scholar
• Sconce EA, Kamali F. Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen. Eur J Haematol. 2006;77(6):457–462.
   PubMed Web of Science ®Google Scholar
• Makohusova M, Mrazova V, Bednarova A, et al. Comparison of two different techniques of warfarin dosing determination - a chemometrics study. Iran J Pharm Res. 2019;18(2):1010–1019.
   PubMed Web of Science ®Google Scholar
• Jorgensen AL, Prince C, Fitzgerald G, et al. Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study. BMC Med. 2019;17(1):76.
   PubMed Web of Science ®Google Scholar
• Ogendo SW. Warfarin-related bleeding following open heart surgery in Nairobi. East Afr Med J. 2001;78(3):139–143.
   PubMedGoogle Scholar
• Kibiru A. Adequacy of oral anticoagulation therapy among ambulatory patients at Kenyatta National Hospital. Nairobi; 2012. [cited 2019 Oct 10]. Available from: http://erepository.uonbi.ac.ke/bitstream/handle/11295/8262/Kibiru_Adequacy%20of%20Oral%20Anti%20coagulation%20Therapy%20Among%20Ambulatory%20Patients%20at%20the%20Kenyatta%20National%20Hospital%2c%20Nairobi.pdf?sequence=1&isAllowed=y
   Google Scholar
• Mariita K, Nyamu DG, Maina CK, et al. Patient factors impacting on oral anticoagulation therapy among adult outpatients in a Kenyan referral hospital. Afr J Pharmacol Ther. 2016;5(3):193–200.
   Google Scholar
• Mariita K, Nyamu D, Maina C, et al. Patient associated factors that affect adherence to warfarin therapy in a tertiary referral hospital in Kenya. East Cent Afr J Pharm Sci. 2015;18:67–74.
   Google Scholar
• Nyamu DG, Guantai AN, Osanjo GO, et al. Predictors of adequate ambulatory anticoagulation among adult patients in a tertiary teaching and referral hospital in Kenya. Afri J Pharmacol Ther. 2017 24;6(1):20–26.
   Google Scholar
• Nyamu GD, Guantai AN. Patterns of ambulatory anticoagulation practices in a county hospital in Nairobi. PJK. 2018;23(3):75–82.
   Google Scholar
• Iqbal S Effect of a designed warfarin based education program on patients’ knowledge and anticoagulation control among adult outpatients attending clinics at Kenyatta National Hospital. 2017. [cited 2019 Oct 1]. Available from: https://pdfs.semanticscholar.org/8c9e/ed087e09babf640154648cd45921c41d9d4d.pdf
   Google Scholar
• Anderson FA Jr., Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9–16.
   PubMed Web of Science ®Google Scholar
• Hansson PO, Eriksson H, Welin L, et al. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: “the study of men born in 1913”. Arch Internal Med. 1999;159(16):1886–1890.
   PubMed Web of Science ®Google Scholar
• Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118(9):978–980.
   PubMed Web of Science ®Google Scholar
• Mkuu RS, Epnere K, Chowdhury MAB. Prevalence and predictors of overweight and obesity among Kenyan women. Prev Chronic Dis. 2018;15:E44.
   PubMed Web of Science ®Google Scholar
• Mbochi RW, Kuria E, Kimiywe J, et al. Predictors of overweight and obesity in adult women in Nairobi province, Kenya. BMC Public Health. 2012;12:823.
   PubMed Web of Science ®Google Scholar
• Amugsi DA, Dimbuene ZT, Mberu B, et al. Prevalence and time trends in overweight and obesity among urban women: an analysis of demographic and health surveys data from 24 African countries, 1991–2014. BMJ Open. 2017;7(10):e017344.
   PubMed Web of Science ®Google Scholar
• Obulutsa JN Rural urban prevalence and associated factors of overweight and obesity in adult patients seeking healthcare: a case of Pcea Kikuyu Hospital, Kenya. 2015. [cited 2019 Oct 5]. Available from: https://pdfs.semanticscholar.org/c406/1ea228749d55f04d215b8b06c53dad867e7e.pdf
   Google Scholar
• Kanyi J, Karwa R, Pastakia SD, et al. Venous thromboembolism requiring extended anticoagulation among HIV-infected patients in a rural, resource-constrained setting in Western Kenya. Ann Pharmacother. 2017;51(5):380–387.
   PubMed Web of Science ®Google Scholar
• Aregbeshola BS, Khan SM. Out-of-pocket payments, catastrophic health expenditure and poverty among households in Nigeria 2010. Int J Health Policy Manag. 2018;7(9):798–806.
   PubMed Web of Science ®Google Scholar
• Mapa-Tassou C, Katte JC, Mba Maadjhou C, et al. Economic impact of diabetes in Africa. Curr Diab Rep. 2019;19(2):5.
   PubMed Web of Science ®Google Scholar
• Cameron A, Ewen M, Ross-Degnan D, et al. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–249.
   PubMed Web of Science ®Google Scholar
• Barlett JE, Kotrlik JW, Higgins CC. Organizational research: determining appropriate sample size in survey research. Inf Technol Learn Perform J. 2001;19(1):43.
   Google Scholar
• KARURI SW, NYAMU DG, OPANGA SA, et al. Factors associated with time in therapeutic range among patients on oral anticoagulation therapy in a tertiary teaching and referral hospital in Kenya. East Cent Afr J Pharm Sci. 2019;22:85−95.
   Google Scholar
• Voeten HA, O’Hara HB, Kusimba J, et al. Gender differences in health care-seeking behavior for sexually transmitted diseases: a population-based study in Nairobi, Kenya. Sex Transm Dis. 2004;31(5):265–272.
   PubMed Web of Science ®Google Scholar
• Bernard C, Pekny C, Omukagah CO, et al. Integration of contraceptive services into anticoagulation management services improves access to long-acting reversible contraception. Contraception. 2018;98(6):486–491.
   PubMed Web of Science ®Google Scholar
• Cois A, Day C. Obesity trends and risk factors in the South African adult population. BMC Obes. 2015;2:42.
   PubMedGoogle Scholar
• Mbui JM, Oluka MN, Guantai EM, et al. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications. Expert Rev Clin Pharmacol. 2017;10(11):1263–1271.
   PubMed Web of Science ®Google Scholar
• MoH. Republic of Kenya Ministry of Health. Kenya national strategy for the prevention and control of non-communicable diseases 2015 to 2020. [cited 2019 Oct 15]. Available from: http://www.who.int/nmh/ncd-task-force/kenya-strategy-ncds-2015-2020.pdf
   Google Scholar
• Ogendo SW. Pattern of anticoagulation control after heart valve surgery at the Kenyatta National Hospital, Nairobi. East Afr Med J. 2000;77(7):354–358.
   PubMed Web of Science ®Google Scholar
• Makubi A, Lwakatare J, Nordrehaug J, et al. Anticoagulant control results among patients with mechanical heart valves at Muhimbili National Hospital, Tanzania. Tanzan Med J. 2008;23(1):12–15.
   Google Scholar
• Mwita JC, Francis JM, Oyekunle AA, et al. Quality of anticoagulation with warfarin at a tertiary hospital in Botswana. Clin Appl Thromb Hemost. 2018;24(4):596–601.
   PubMed Web of Science ®Google Scholar
• Aranki SF, Rizzo RJ, Couper GS, et al. Aortic valve replacement in the elderly. Effect of gender and coronary artery disease on operative mortality. Circulation. 1993;88(5 Pt 2):Ii17–23.
   PubMed Web of Science ®Google Scholar
• Rogers SO Jr., Kilaru RK, Hosokawa P, et al. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007;204(6):1211–1221.
   PubMed Web of Science ®Google Scholar
• Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8(3):162–172.
   PubMed Web of Science ®Google Scholar
• Zoni-Berisso M, Lercari F, Carazza T, et al. Epidemiology of atrial fibrillation: european perspective. Clin Epidemiol. 2014;6:213–220.
   PubMed Web of Science ®Google Scholar
• Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: virchow’s triad revisited. Lancet. 2009;373(9658):155–166.
   PubMed Web of Science ®Google Scholar
• Chan MY, Andreotti F, Becker RC. Hypercoagulable states in cardiovascular disease. Circulation. 2008;118(22):2286–2297.
   PubMed Web of Science ®Google Scholar
• Serlin MJ, Breckenridge AM. Drug interactions with warfarin. Drugs. 1983;25(6):610–620.
   PubMed Web of Science ®Google Scholar